Skip to content
2000
Volume 22, Issue 19
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

The evolution of polymer-based nanoparticle as a drug delivery carrier has greatly contributed to the development of advanced nano and micro-medicine in the past few decades. The polymer-based nanoparticles of biodegradable and biocompatible polymers such as poly (lactide-co-glycolide) and chitosan which have been approved by Food & Drug Administration and/or European Medicine Agency can particularly facilitate the maintaining of specific properties for a real transition from laboratory to the clinical oral and parental administration. This review presents an overview of the strategies of preparing polymeric nanoparticles and using them for targeting colorectal cancer. Theranostics and surface engineering aspects of nanoparticle design in colonic cancer delivery are also highlighted.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612822666160217140932
2016-05-01
2025-05-06
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612822666160217140932
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test